OMEGAVEN AND PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS

Omegaven 和肠外营养相关的胆汁淤积

• 批准号: 8167144
• 负责人: Kara Lynne Calkins
• 金额: $ 0.07万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167144
• 关键词: Cholestasis; Computer Retrieval of Information on Scientific Projects Database; Fish Oils; Funding; Grant; Institution; Intravenous; Liver diseases; Parenteral Nutrition; Pilot Projects; Research; Research Personnel; Resources; Source; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The specific aim of this pilot study is to investigate if intravenous (IV) fish oil (FO), commercially available as Omegaven? (Fresenius Kabi), at 1 gm/kg/d for no longer than 24 weeks, will safely reverse or ameliorate liver disease in 15 subjects with PNAC

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项试点研究的具体目的是调查，如果静脉注射（IV）鱼油（FO），市售的Omegaven？（Fresenius Kabi），1 gm/kg/d，持续不超过24周，将安全地逆转或改善15例PNAC受试者的肝脏疾病